FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox
Posted
Frank Vinluan (via MedCity News)
Emergent BioSolutions’ smallpox vaccine, ACAM2000, now has an additional FDA approval covering mpox. It’s one of two FDA-approved mpox vaccines, joining Jynneos from Bavarian Nordic.
The post FDA Approves Emergent BioSolutions Vaccine as New Tool in Fight Against Mpox appeared first on MedCity News.
